PRMT5-mediated FUBP1 methylation accelerates prostate cancer progression.
Yan W, Liu X, Qiu X, Zhang X, Chen J, Xiao K, Wu P, Peng C, Hu X, Wang Z, Qin J, Sun L, Chen L, Wu D, Huang S, Yin L, Li Z.
Yan W, et al. Among authors: liu x.
J Clin Invest. 2024 Aug 15;134(18):e175023. doi: 10.1172/JCI175023.
J Clin Invest. 2024.
PMID: 39146021
Free PMC article.